Safety and efficacy of rotigotine in patients with frontotemporal dementia: a phase 2, double-blind, randomized, placebo-controlled, multicenter trial

This trial was funded by a joint grant from the Alzheimer Drug Discovery Foundation (ADDF) and the Association for Frontotemporal Degeneration (AFTD) grant to GK and BB (GFTD-201902-2017958).

Authors

Institutions

Publication Details

Journal
The Lancet Regional Health - Europe
Published
2025-08-05
DOI
https://doi.org/10.1016/j.lanepe.2025.101409
Citations
2
Primary Topic
Neurological Disorders and Treatments
Type
article
Field-Weighted Citation Impact
1.68

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Safety and efficacy of rotigotine in patients with frontotemporal dementia: a phase 2, double-blind, randomized, placebo-controlled, multicenter trial

Valentina Pezzopane, Caterina Motta, Elias Paolo Casula, Pasquale Romano et al.
2 citations
The Lancet Regional Health - Europe
Neurological Disorders and Treatments
1.68
article

Safety and efficacy of rotigotine in patients with frontotemporal dementia: a phase 2, double-blind, randomized, placebo-controlled, multicenter trial

Valentina Pezzopane, Caterina Motta, Elias Paolo Casula, Pasquale Romano, Francesco Di Lorenzo, Sonia Bonnı̀, Enrico Premi, Michele Maiella, Clarissa Ferrari, Silvia Lucchini, Romina Esposito, Martina Assogna, Emanuele Cerulli Irelli, Luca Battistini, Alessia D’Acunto, Yasmine Gadola, Ilaria Borghi, Giacomo Koch, Antonella Alberici, Gisella Guerrera, Francesco Bertagna, Lucia Mencarelli, Barbara Borroni, Valeria Bracca, Matteo Ferraresi, Alessandro Martorana, Antonio Daniele, Francesca Candeo, Andrea Ludovici
article en
2 citations

Abstract

This trial was funded by a joint grant from the Alzheimer Drug Discovery Foundation (ADDF) and the Association for Frontotemporal Degeneration (AFTD) grant to GK and BB (GFTD-201902-2017958).

The Lancet Regional Health - EuropeVol. 57
Università Cattolica del Sacro Cuore (IT), University of Rome Tor Vergata (IT), Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (IT), Centro San Giovanni di Dio Fatebenefratelli (IT), Center for Translational Neurophysiology of Speech and Communication (IT), Fondazione Poliambulanza Istituto Ospedaliero (IT), Fondazione Santa Lucia (IT), Libera Università Internazionale degli Studi Sociali Guido Carli (IT), University of Brescia (IT), Sapienza University of Rome (IT)
Alzheimer's Drug Discovery Foundation, BrightFocus Foundation, Jazz Pharmaceuticals, European Commission, Ministero della Salute, Ministero dell’Istruzione, dell’Università e della Ricerca, Angelini Pharma
Good health and well-being
Openalex Percentile: Top 14%
Neurological Disorders and Treatments
1.68
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.